Cardiac hypertrophy in response to multiple stimuli has important physiological and pathological significances. GATA4 
Introduction

Hypertrophic signals change the transcriptional program and eventually result in cardiac hypertrophy. At the cellular level, cardiac hypertrophy is characterized by an increase in cell size and reactivation of foetal gene programs, as well as cytoskeletal reorganization. Large-scale expression and functional analyses have identified numerous transcription factors responsible for cardiac hypertrophy, including the general transcription factors AP1, NF-B, NF-AT, c-myc and p300
, and cardiac-specific transcription factors such as GATA4, SRF, MEF2C and NKX2.5 [1] . [2, 3] . Functional [4] . Overexpression of GATA4 alone led to cardiac hypertrophy both in cultured cardiomyocytes and transgenic mice, accompanied by up-regulated expression of ANF and other foetal genes [5, 6] . The [1, [7] [8] [9] [10] [11] [12] [13] . It is notable that GATA4 can function as a molecular bridge or scaffold linking multiple nuclear factors such as p300, MEF2C, SRF, NKX2.5, NF-AT and AP1 during cardiac hypertrophy [1, 13] .
GATA4 has been recognized as a pivotal effector mediating cardiac gene transcription in response to hypertrophic stimuli. Targeted disruption of GATA4 showed that it is indispensable for terminal differentiation and survival of cardiac myocytes
GATA-binding sites have been identified within the promoters of several cardiac genes, including atrial natriuretic factor (ANF), brain natriuretic peptide (BNP), ␣-myosin heavy chain (␣-MHC) and ␤-MHC
GATA families cooperate with Sp proteins, classically thought of as part of the basal transcriptional machinery, to mediate the expression of some tissue-specific genes [14] . The Sp family contains at least four members [15, 16] [16] . Because Sp3 can inhibit Sp1-mediated transcription via competitive occupation, the ratio of Sp1/Sp3 affects the regulation of several genes [17, 18] . It 
, all having three zinc finger binding domains located at the C-terminal region for DNA binding and varying stretches of serine/threonine domains at the N-terminal region. Sp1 binds specifically to GC-rich sequences and is involved in the activation of promoters of various genes. Although Sp3 has the same binding specificity and ability as Sp1, its effect as an activator or repressor of transcription is mainly dependent on cell type, DNA-binding sites and its interactions with other nuclear factors. Sp3 often acts as a transcriptional repressor by competitively binding to the Sp1-bound GC box sequences and/or by directly functioning as a potent inhibitor
Cardiomyocytes culture
Neonatal rat ventricular myocytes (hereafter referred as cardiomyocytes) were prepared and cultured as previously described [23] 
Luciferase assays
Cells were seeded at a density of 10 ϫ 10 4 per well in a 24-well plate and transfected using Lipofectamine™2000 (Invitrogen, Carlsbad, CA, USA) when they reached 80% confluence. Luciferase assays were performed as previously described [24] .
Immunocytochemistry
The cardiac myocytes were cultured in flask-style chambers on glass slides. Indirect immunofluorescent staining for ␣-actinin (A7811; Sigma Chemical) was performed using FITC-conjugated secondary antibody to visualize cellular morphology.
Western blot analysis
Western blots were performed as previously described [24] . 
Immunoprecipitation assay
Forty-eight hours after transfection, HeLa cells were harvested and lysed at 4ЊC in immunoprecipitation cell lysis buffer. Immunoprecipitations were performed using the anti-FLAG M2 affinity gel (A2220; Sigma Chemical) as previously described [24] . . Bound proteins were visualized by autoradiography as described previously [25] . To evaluate the effect of the S105 site of GATA4 for binding with Sp1 protein, HeLa cells were transfected with either the wild-type or S105A mutant of FLAG-GATA4 vector and subsequently treated as described earlier.
GST pull-down assays
RT-PCR
RNA extraction was performed using Trizol Reagent (Invitrogen) based on the manufacturer's instructions. Amplifications were performed in a T-gradient thermocycler (Biometra, Gottingen, Germany) with different primers and condition (Table 3) .
Chromatin immunoprecipitation (ChIP) assay
ChIP experiments were performed according to the method described previously [24] . After cross-link reversal, precipitated DNA was analysed 
Name
Primer sequences
GATA4-Nf Forward 5Ј-CTGAATTCATGTTCTCAGAAGGCAGAGAG-3Ј
Reverse 5Ј-ATCTCGAGCAGCCGGCGCTGAGGCTT-3Ј
Reverse 5Ј-GACTCGAGTTACGCGGTGATTATGTC-3Ј 
by PCR for fragments of the proximal ANF promoter with different primers and condition (Table 4) .
Electrophoretic mobility shift assays (EMSA)
The human recombinant protein Sp1 was purchased from Promega Company (E639A). Nuclear extracts were prepared from cardiomyocytes treated as described [24] . 
Construction of Ad-GATA4
Results
Involvement of GATA4, Sp1/Sp3 in cardiac hypertrophy
To elucidate whether Sp1 and Sp3 participate in cardiac hypertrophy, we created pressure-overload hypertrophy models induced by aortic stenosis [21] [26] . The expressions of GATA4 and Sp1 are up-regulated, whereas Sp3 is downregulated in rats with pressure overload hypertrophy 7 weeks after aortic banding (Fig. 1A) . PE is a ␣1-adrenoceptor agonist and is often used as a prohypertrophic stimulus. Cardiomyocytes stimulated by PE displayed an increase in cell size, total protein content and reorganization of myofibrils (Fig. 1B and C) . Meanwhile, PE stimulation greatly increased the expression of foetal gene ANF and the expression of GATA4 and Sp1, whereas expression of Sp3 decreased (Fig. 1D) . Fig. 2A) . GATA4 cotransfected with increasing amount of Sp1 vector stimulated ANF promoter activity in a dose-dependent manner (Fig. 2B) . No significant cooperation occurred between Sp1 and Nkx2.5, dHAND or MEF2C (Fig. 2A) . In contrast, co-transfection of GATA4 with Sp3 produced an additive rather than a synergetic effect ( Fig. 2A) , although Sp3 and Sp1 share some homologies in both structure and function. Similar results were also obtained from transient transfection with ␤-MHC promoter (Fig. 2C) . These results indicate a transcriptional synergy between GATA4 and Sp1, but not Sp3.
and PE-induced neonatal cardiomyocyte hypertrophy. About 7 weeks after aorta banding, the status of CHT (compensated hypertrophy) was identified by increased left ventricle wall thickness and normal contractile indices
Transcriptional synergy between GATA4 and Sp1
To reveal whether there was an interaction between Sp proteins and GATA4 in regulating hypertrophic gene expression, we first performed luciferase reporter assays. Co-transfection of GATA4 and Sp1 in HeLa cells increased ANF promoter activity 24-fold over the basal promoter activity alone (
Table 4 Primers used in ChIP assay
Name
Previous reports found that Sp1 reduced the co-activation of serum response elements (SRF) and GATA4 or Nkx2.5 on the cardiac ␣-actin promoter [27] . However, in our system, Sp1 further increased the synergetic transcriptional activities between GATA4 and other cardiac-specific transactivators (Fig. 2D) . Furthermore, overexpression of Sp3 or dominant-defective Sp1 (GST-Sp1) inhibited the co-activation of Sp1 and GATA4 (Fig. 2E) 
Interactions between GATA4 and Sp1 in vivo and in vitro
The functional synergy indicates an indirect or direct interaction between GATA4 and Sp1. Immunoprecipitation assays showed that Sp1, not Sp3, strongly interacts with GATA4 (Fig. 3A) , consistent with results of the luciferase reporter assays. To further map the interaction between GATA4 and Sp1, GST pull-down assays were performed. As shown in Figure 3B , the C-terminal zinc finger of GATA4 is the major domain interacting with Sp1 rather than Sp3. Similarly, as shown in Figure 3C , truncated Sp1 fragments were capable of interacting strongly with GATA4 as long as they retain the zinc finger domain.
Identification of Sp-binding sites on the proximal region of ANF
We further analysed this proximal region of the ANF gene and found four potential binding sites for Sp proteins, S1, S2, S3 and S4 (Fig. 4A) . Using EMSA, we confirmed that four oligonucleotide probes, each containing one of the S1-S4 sites, could complex with purified Sp1 (Fig. 4B) Figure 4C , once all four Sp-binding sites on the ANF promoter were destroyed, the transcriptional cooperation between Sp1 and GATA4 was attenuated but not completely diminished.
We also performed luciferase assays in cardiomyocytes. As shown in Figure 4D, (Fig. 5A) . The recruitment of GATA4 to the ANF promoter was also enhanced after PE stimulation (Fig. 5A) . Forced GATA4 expression resulted in a significant increase in cardiomyocyte surface area and ANF expression (Fig. 5B) , as well as in the DNA-binding activity of Sp1, but not Sp3, on the ANF promoter (Fig. 5C) Figure 5E , in the presence of PE, the transcriptional activity of ANF promoter was greatly increased, which was partly attenuated by co-transfection with Sp3 or GST-Sp1. Meanwhile, GATA4 and Sp1 synergistically activated ANF promoter in cardiomyocytes with or without PE stimulation (Fig. 5F ).
Fig. 2 Transcriptional effects of Sp1/Sp3 and GATA4 on ANF promoter. Luciferase assays were performed in HeLa cells to evaluate the effects of Sp1 or Sp3 with other transcriptional factors on the ANF-638 bp promoter-luciferase reporter construct (ANF-luc) in (A), (B), (D) and (E), or ␤-MHC promoter-luciferase reporter construct (␤-MHC-luc) in (C). GST-Sp1 is a dominant-negative mutant of Sp1, which contains an intact DNA-binding region without an activation domain on the N-terminus and thus competitively blocks putative
. However, Sp1 expression was not affected by GATA4 overexpression, indicating that the enhanced expression and recruitment of GATA4 under PE stimulation might further increase the recruitment of Sp1 on ANF promoter but not Sp1 expression. Consistent with the binding of Sp1 onto its consensus sites, Sp1 activated ANF promoter in cardiomyocytes while Sp3 or GSTSp1 (the dominant negative mutant) exhibited a repression effect on reporter activity (Fig. 5D). Because Sp3 could inhibit ANF promoter activity in cardiomyocytes, we investigated whether Sp3 could inhibit ANF expression in cardiac hypertrophy. As shown in
Reinforced recruitment of Sp1 by phosphorylated GATA4
It has been reported that phosphorylation of GATA4 at Ser105 by ERK1/2 kinase could enhance the transcriptional activity and DNA-binding affinity of GATA4 [10] . As shown in Figure 6A , the DNA-binding activity of GATA4 was attenuated after cardiomyocytes were treated with PD98059 (ERK1/2 inhibitor) or when GATA4 Ser105 was mutated. We speculated that phosphorylation triggered conformational changes in GATA4, leading to higher affinity with basal transcriptional apparatus such as Sp1. We thus measured the effect of phosphorylation of GATA4 on recruitment of Sp1. As shown in Figure 6B , when phosphorylation of GATA4 was interfered with by the application of PD98059 or Ser105 mutation, the level of Sp1 immunoprecipitated by GATA4 was reduced, suggesting that phosphorylation of GATA4 plays an important role in recruiting Sp1. GATA4 S105A mutant also exhibited lower efficiency than wild type in cooperation with Sp1 35 
B) GST pull-down experiments were performed with cell lysates from HeLa cells transfected with Sp1 or Sp3 in combination with various fragments (as shown in the upper panel) of GATA4 fused to GST and then analysed by SDS-PAGE and Western blot. N, Nf, Cf and C stand for N terminal, N terminal zinc finger, C terminal zinc finger and C terminal domain, respectively. The middle panel shows GSTfusion proteins stained by Coomassie brilliant blue. The precipitated complexes were detected with Sp1 or Sp3 antibodies (the bottom panel). An equal amount of GST protein was used as a negative control. (C) GST pull-down was performed to analyse the interaction between in vitro translated
S-labelled various fragments of Sp1 and GATA4 fused to GST. The labelled fragment bond with GATA4 was visualized by autoradiography. All the experiments
were repeated at least three times. 32 
Fig. 4 Sp1/Sp3 binding on ANF promoter and the effects on ANF promoter activity. (A) The schematic diagram shows the putative GC boxes (S1, S2, S3 and S4) for Sp1/Sp3 and consensus sequences for GATA4 (GATA) in the proximal region of the rat ANF promoter. (B) EMSA assays were performed with purified Sp1 protein to analyse its binding ability with
P-labelled rat ANF S1, S2, S3 and S4 probes, respectively. The specific bands of Sp1 are indicated. (C, D) Luciferase assays were performed to evaluate the contributions of the Sp-binding sites to ANF promoter activity. HeLa cells (C) were co-transfected with GATA4 and Sp1 in combination with wild-type ANF luciferase-reporter construct (wt) or mutant ANF luciferase constructs (s1234) containing mutations in the four Sp-binding sites. (D) shows the results obtained in neonatal cardiomyocytes. The mutant ANF luciferase constructs include mutations in one or more Sp-binding sites (as indicated on the y-axis). (Each bar represents mean Ϯ S.D. from three independent experiments; *P Ͻ 0.05.)
to activate the ANF promoter, especially when the ERK1 pathway was activated (Fig. 6C) . Consistent with these findings, we also observed that in vivo phosphorylation of ERK1/2 and GATA4 S105 were enhanced (Fig. 6D) and the level of p-GATA4 S105 immunoprecipitated by Sp1 was also increased in response to PE stimulation in cardiomyocytes (Fig. 6E) . Thus, our data established a mechanism by which GATA4 phosphorylated by ERK1/2 kinases can recruit Sp1 and convey hypertrophic response to Sp1. It has been reported that GATA4 could play important roles in the process of cardiac hypertrophy [1, 6] Sp1 [14] . Sp1 could have direct interaction with GATA1 erythroid specific promoter [28] . Therefore Fig. 2 and 6C ) but also in rat neonatal cardiomyocytes (Fig. 5F ). The association between hypertrophy and the expression level of transcription factors demonstrated in cardiac tissue (Fig. 1A) was also present in cardiomyocytes as shown in Figure 1D [35, 36] , whereas miR-1 also negatively regulated the expression of MEF2a and GATA4 [37] . Therefore, the regulation of cardiac hypertrophy must be complicated. More detailed mechanisms of Sp1 and GATA4 regulation in cardiac hypertrophy remain to be discovered.
